Who Are We
Frontage is a full service CRO which closely collaborates with pharmaceutical and biotech companies to help them bring promising drug candidates to market. With 14 locations in USA and China, Frontage has been assisting clients in their drug development efforts since 2001.
Spanning from preclinical through late-stage development, it’s full service offerings include:
- Bioanalytical Services for Small and Large Molecule and Biomarkers
- Early Stage Clinical Services
- Full Biometrics Support
Frontage also provides turnkey product development services to generic, innovator and consumer health companies to support IND, NDA, ANDA, and 505(b)(2) submissions. What sets us apart is our ability to collaborate closely with our clients to ensure a deep understanding of their drug development goals and our ability provide flexible solutions that are customized to each client’s needs.
At Frontage, we are committed to providing rigorous scientific expertise to ensure the highest quality and compliance on each project. Frontage proudly serves innovator, generic and consumer health companies from IND enabling through late stage clinical projects. Frontage successfully assists clients to advance hundreds of molecules through development to commercial launch in global markets. This partnership with our clients is how we turn services into real solutions that get our clients ahead.
The Value We Provide
With 70% of our scientists holding advanced degrees and our depth & breadth of experience, we can solve complex problems
We have an unparalleled compliance and quality track record with 32 FDA Inspections across GXP
We value agile project management, & a commitment to completing projects on time and on budget
Our $40M facility investment and 500+ FTE in USA & China give us the latest equipment and unparalleled access to China